Q1 2024 Holdings
Filed 2024-05-14 | 22 holdings | $745.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alpine Immune Sciences, Inc.(NVLSEUR) | COM | 02083G100 | $329.7M | 8,317,924 | 44.2% |
| CG Oncology Inc(CGON) | COM | 156944100 | $239.6M | 5,458,810 | 32.1% |
| Zentalis Pharmaceuticals Inc.(ZNTL) | COM | 98943L107 | $33.1M | 2,099,583 | 4.4% |
| Illumnia, Inc.(ILMN) | COM | 452327109 | $17.7M | 129,067 | 2.4% |
| BeyondSpring Inc.(BYSI) | SHS | G10830100 | $17.7M | 4,958,143 | 2.4% |
| Arcus Biosciences, Inc(RCUS) | COM | 03969F109 | $16.4M | 869,790 | 2.2% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $11.7M | 65,772 | 1.6% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $11.1M | 347,835 | 1.5% |
| Equillium Inc.(EQ) | COM | 29446K106 | $10.3M | 4,447,308 | 1.4% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $9.0M | 850,000 | 1.2% |
| Moonlake Immunotherapeutics | COM | G4444C102 | $8.4M | 166,600 | 1.1% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $7.4M | 157,958 | 1.0% |
| 10x Genomics, Inc.(TXG) | CL A COM | 88025U109 | $7.3M | 195,835 | 1.0% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $6.6M | 94,043 | 0.9% |
| Legend Biotech Corp(LEGN) | ADR | 52490G102 | $4.8M | 86,363 | 0.6% |
| Merus NV | COM | N5749R100 | $4.6M | 101,798 | 0.6% |
| Aura Biosciences, Inc.(AURA) | COM | 05153U107 | $4.0M | 515,555 | 0.5% |
| Cue Health Inc.(HLTHQ) | COM | 229790100 | $1.7M | 8,980,909 | 0.2% |
| Pyxis Oncology, Inc (formerly Apexigen)(PYXS) | COM | 747324101 | $1.4M | 326,810 | 0.2% |
| Aadi Bioscience, Inc.(WHWK) | COM | 00032Q104 | $1.2M | 526,329 | 0.2% |
| GeneDx Holdings Corp.(WGS) | COM CL A | 81663L200 | $945.9K | 103,604 | 0.1% |
| AtriCure Inc.(ATRC) | COM | 04963C209 | $815.2K | 26,797 | 0.1% |